Massachusetts Financial Services CO Intercept Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$9.99 - $18.71 $227,791 - $426,625	22,802 Added 31.35%	95,547 $1.77 Million
Q2 2023 Aug 09, 2023	SELL	$9.17 - $19.29 $15,717 - $33,063	-1,714 Reduced 2.3%	72,745 $804,000
Q1 2023 May 10, 2023	SELL	$12.53 - $21.71 $1.07 Million - $1.85 Million	-85,004 Reduced 53.31%	74,459 $999,000
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $39,195 - $54,387	3,376 Added 2.16%	159,463 $1.97 Million
Q3 2022 Nov 09, 2022	SELL	$12.21 - $19.7 $17,374 - $28,033	-1,423 Reduced 0.9%	156,087 $2.18 Million

Q2 2022 Aug 09, 2022	BUY	$11.23 - $19.59 $8,927 - $15,574	795 Added 0.51%	157,510 $2.18 Million
Q1 2022 May 11, 2022	BUY	$13.37 - $17.79 $21,485 - $28,588	1,607 Added 1.04%	156,715 $2.55 Million
Q4 2021 Feb 10, 2022	BUY	$14.28 - $19.53 $1.47 Million - $2.01 Million	102,965 Added 197.47%	155,108 $2.53 Million
Q3 2021 Nov 10, 2021	BUY	$12.99 - $20.47 $677,337 - $1.07 Million	52,143 New	52,143 $774,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.